The effects of DNA formulation and administration route on cancer therapeutic efficacy with xenogenic EGFR DNA vaccine in a lung cancer animal model

BACKGROUND: Tyrosine kinase inhibitor gefitinib is effective against lung cancer cells carrying mutant epidermal growth factor receptor (EGFR); however, it is not effective against lung cancer carrying normal EGFR. The breaking of immune tolerance against self epidermal growth factor receptor with a...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Lai, Ming-Derg, Yen, Meng-Chi, Lin, Chiu-Mei, Tu, Cheng-Fen, Wang, Chun-Chin, Lin, Pei-Shan, Yang, Huei-Jiun, Lin, Chi-Chen
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2009
विषय:
Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2645394/
https://ncbi.nlm.nih.gov/pubmed/19178753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-0556-7-2
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन